English
Home > Products > 598-10-7

China 598-10-7 Factory

We emphasize growth and introduce new goods into the market every year for 598-10-7,CAS NO 598-10-7,Cabozantinib intermediate,Cabozantinib advance intermediate,1,1-Cyclopropanedicarboxylic acid, Our aim is "blazing new ground, Passing Value", in the future, we sincerely invite you to grow up with us and make a bright future together!
598-10-7, Our objects have national accreditation requirements for qualified, high quality products and solutions, affordable value, was welcomed by people today all over the world. Our goods will continue to enhance within the order and look forward to cooperation with you, Need to any of those goods be of interest to you, be sure to letus know. We've been gonna be content to offer you a quotation up on receipt of your detailed needs.

Related Products

Hot Products

  • 4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile

    4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile

    Product Name:4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile
    Molecular Formula:C14H10BrNO2
    Molecular Weight:304.14
    CAS Registry Number:906673-45-8
  • 2-Chloroadenine

    2-Chloroadenine

    Product Name:2-Chloroadenine
    Molecular Formula:C5H4ClN5
    Molecular Weight:169.57
    CAS Registry Number:1839-18-5
  • 3-Amino crotonic acid cinnamyl ester

    3-Amino crotonic acid cinnamyl ester

    Product Name:3-Amino crotonic acid cinnamyl ester
    Molecular Formula:C13H15NO2
    Molecular Weight:217.26
    CAS Registry Number:103909-86-04
  • 3-CHLORO-4-FLUOROTOLUENE

    3-CHLORO-4-FLUOROTOLUENE

    Product Name:3-CHLORO-4-FLUOROTOLUENE
    Molecular Formula:C7H6ClF
    Molecular Weight:144.57
    CAS Registry Number:1513-25-3
  • 2,4-Difluorobenzotrifluoride

    2,4-Difluorobenzotrifluoride

    Product Name:2,4-Difluorobenzotrifluoride
    Molecular Formula:C7H3F5
    Molecular Weight:182.09
    CAS Registry Number:64248-61-9
  • Famciclovir

    Famciclovir

    Product Name:Famciclovir
    Molecular Formula:C14H19N5O4
    Molecular Weight;321.33
    CAS Registry Number;104227-87-4
  • Related Blog
  • Reviews

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

Related Search

CAS NO 598-10-7

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept